| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 37.4× | −1.7× | |
| Price / Book | 7.2× | 2.0× | |
| Price / Sales | 7.0× | 3.9× | |
| Price / Free cash flow | 42.3× | −1.6× | |
| EV / EBITDA | 27.4× | −1.2× | |
| Earnings yield | 2.7% | −14.6% | |
| Free cash flow yield | 2.4% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,249.46 | −0.60% | $1.18T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $254.42 | −0.45% | $613.13B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $283.65 | −0.62% | $501.24B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $406.20 | +1.19% | $364.6B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $143.97 | −1.36% | $355.2B | 19.7× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.47 | −0.10% | $278.36B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $164.47 | −0.57% | $255.08B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $680.51 | −1.38% | $251.62B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $426.69 | −1.34% | $230.68B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $154.10 | −1.34% | $191.08B | 22.8× | 37.5% | +32.0% |
